Jan 3, 2013. FDA issued a draft (out for comment) revision to their Guidance “Guidance for Industry on Providing Regulatory Submissions in Electronic Format-Certain Human Pharmaceutical Product Applications and Related Submissions Using the Electronic Common Technical Document Specification”. Continue reading
Regxia is excited to announce our second showing at the DIA Annual Euromeeting in Amsterdam, The Netherlands March 4-6! We hope you are able to visit us at Booth 834 while we are there! Continue reading
Health Canada plans to launch a Canadian Clinical Trials Registry
Dec 13, 2012. Health Canada has plans to pursue the development of mandatory requirements for the registration and disclosure of clinical trials and study results. In the interim, Health Canada intends to provide access to its internal clinical trial database. Health Canada’s clinical trial database is generally updated by about 800 clinical trials per year, for the study of drugs in patients. Continue reading
Welcome to The Regxia Review!
Regxia is a unique scientific and regulatory consulting firm serving the pharmaceutical and biotech industries. At Regxia we strive to provide personalized attention focusing on your specific regulatory needs. Our clients are our primary focus. As such our team of experts wanted to commit ourselves to providing the most relevant and up-to-date resources and information to you.
Add The Regxia Review to your browser’s favourite list to have access to the most important changes and updates concerning the pharmaceutical and biotech industries.